Next Article in Journal
Increased Mortality Rates During the 2025 Chikungunya Epidemic in Réunion Island
Previous Article in Journal
Targeting SARS-CoV-2 Main Protease: A Bacteria-Based Colorimetric Assay for Screening Natural Antiviral Inhibitors
Previous Article in Special Issue
Probing Viral Dark Matter: Comparative Genomics of Atypical Bacillus Phage YungSlug
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 18
Issue 2
10.3390/v18020179
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diverse Temperate Coliphages of the Urinary Tract

by
Haley Atkins
1,
Natalie Stegman
1 and
Catherine Putonti
1,2,*
1
Bioinformatics Program, Loyola University Chicago, Chicago, IL 60660, USA
2
Biology Department, Loyola University Chicago, Chicago, IL 60660, USA
*
Author to whom correspondence should be addressed.
Viruses 2026, 18(2), 179; https://doi.org/10.3390/v18020179
Submission received: 28 August 2025 / Revised: 15 January 2026 / Accepted: 16 January 2026 / Published: 29 January 2026
(This article belongs to the Special Issue Bacteriophage Diversity, 2nd Edition)
Browse Figures
Versions Notes

Abstract

While Escherichia coli can be found in the bladders of females without lower urinary tract symptoms, its presence is often associated with urinary tract infections (UTIs). The genomic plasticity of E. coli, including urogenital strains, is largely shaped by the integration of prophages. Although genomic and metagenomic analyses of urinary E. coli and the urinary microbiome suggest that prophages are abundant, many represent uncharacterized species. Sequence analysis suggests that these prophages represent temperate phages. This study aimed to fill this gap, isolating and characterizing temperate phages from urinary E. coli strains. We assessed phage host range across a panel of urinary isolates, providing a critical first step for future work investigating their putative role in shaping E. coli populations within the urinary community. In total, 20 temperate urinary phages were evaluated. Phage morphology and genic content of these phages were determined via transmission electron microscopy (TEM) and whole-genome sequencing, respectively. Together, these analyses provide insight into the diversity, infectivity, and genomic composition of temperate coliphages from the female urinary tract.

1. Introduction

Escherichia coli, a common inhabitant of the human gut, is the most frequently identified bacterial species associated with urinary tract infections (UTIs) in females [1]. E. coli is also frequently detected in the bladders of females without urinary symptoms [2,3,4]. The species’ genetic diversity, shaped by their environment and mobile genetic elements, contributes to their ability to adapt to and persist in both the nutrient-rich environment of the gut, as well as the nutrient-limited environment of the bladder [5,6]. One of the most significant contributors to E. coli genome plasticity is the presence of prophages [7,8,9,10]. Prophages are abundant in E. coli, with most E. coli genomes encoding for more than one prophage sequence [5,6,9,10,11,12,13]. The same is true for E. coli strains isolated from the urinary tract; recent genomic studies consistently found that the majority of urinary E. coli strains also include one or more prophage sequences [14,15].
While cryptic prophages, i.e., phages that have integrated and are unable to be induced into the lytic cycle, do not actively produce new virions, they often act as hotspots of recombination within E. coli, contributing to genome plasticity [16]. Temperate phages, or prophages capable of entering the lytic life cycle, often benefit their host. They can accelerate bacterial evolution via horizontal gene transfer (HGT), provide immunity against other phages (superinfection immunity) [17], and confer phenotypic benefits (lysogenic conversion) (see reviews [18,19]). E. coli temperate phages are among the most thoroughly characterized phages, with phage Lambda serving as a model system for lysogeny and phage-host dynamics since the 1950s [20]. Lambdoids are among the most frequent prophages of E. coli [21]. A recent study found an association between lambda phage orientation and (i) genome location of integration and (ii) spontaneous lysis [22]. Despite the benefits of lysogeny, it comes with a cost—excision (induction) of the prophage can cause bacterial host cell death. While detrimental for the individual bacterium, it can be beneficial for the population [23].
Within the human GI microbiota, where temperate phages predominate [24,25,26,27], associations between temperate phages and GI health have emerged (see review [28]). Microbial interactions and external factors can drive prophage shifts from lysogenic to lytic life cycles in the gut, thus modulating the microbial community [29]. In comparison to the gut, the urinary microbiome is not well characterized. Nevertheless, virome studies have found that phages are more abundant than eukaryotic viruses (see review [30]) and lysogeny is widespread (86%) [14]. Our prior analyses of urinary bacterial genomes [14] and urinary E. coli genomes [15] suggest that these prophage sequences are temperate phages. This is further supported by studies that have isolated temperate phages from urinary bacteria [15,30,31,32]. However, characterization of the diversity of temperate phages within the urinary tract has yet to be conducted. A recent study suggests that temperate phages may be contributing to uropathogen colonization [33]. Characterization of these phages is a critical first step in understanding the role of temperate phages within this community and their association (if any) with urinary tract symptoms.
Given the high prevalence of prophages in E. coli genomes, this study aimed to isolate and characterize temperate phages from urinary E. coli isolates. Functional temperate phages were examined to assess their host range, morphology, and genetic composition. Host range assays were performed to evaluate which urinary E. coli strains a given phage can infect. Transmission electron microscopy (TEM) was used to visualize phage morphology based on structural characteristics. In parallel, whole-genome sequencing of the phages provided detailed information about their genetic architecture, lysis/lysogeny genes, and taxonomy. Together, these analyses offer a view of temperate coliphages in the urinary microbiota.

2. Materials and Methods

2.1. Prophage and CRISPR Prediction

The 66 strains of E. coli previously sequenced by our lab [3] were evaluated for the presence of prophages using the tool PHASTER [34]. CRISPR/Cas detection was performed using CRISPRCasFinder with the parameters “general” and “unordered,” which allow a permissive search for CAS genes within contigs respectively [35]. The strains and the number of predicted prophage sequences and CRISPR spacers are listed in Supplemental Table S1.

2.2. Phage Induction

The 66 strains were used for phage induction (Supplemental Table S1). From our freezer stocks, these bacteria were streaked on LB 1.7% agar plates and incubated overnight at 37 °C. Next, 3 mL of LB was inoculated with a single colony from a plate and grown overnight, with shaking at 37 °C. The laboratory strain E. coli C was grown under these same conditions. Each culture of a urinary E. coli strain was filtered with a 0.22 μm syringe filter. The filtrate was spotted (10 μL) onto lawns of E. coli C. Each lawn consisted of 500 μL of overnight E. coli C culture + 3 mL of soft LB agar (0.7% agar) mixed and spread onto an LB agar plate. The spot plates were incubated overnight at 37 °C. Clear plaques were harvested into 0.7% saline, vortexed, and filtered. The filtrate was again plated, this time as pour plates (100 μL filtrate + 3 mL soft LB agar), whereupon individual plaques were harvested. This process of plaque purification was repeated at least three times.

2.3. Phage DNA Extraction, Sequencing, Assembly, and Annotation

Phage DNA from harvested plaques was extracted with the Zymo Quick DNA Viral Kit. Two steps were modified in the manufacturer’s protocol: (1) 300 μL of sample and 1200 μL of Viral DNA Buffer were used and (2) 30 μL of elution buffer was used. The concentration of the DNA was measured via Qubit fluorometer. DNA was sent to SeqCoast Genomics, LLC (Portsmouth, NH, USA) for library preparation and sequencing. Samples were prepared for whole-genome sequencing using an Illumina DNA Prep tagmentation kit and unique dual indexes. Sequencing was performed on the Illumina NextSeq2000 platform (San Diego, CA, USA) using a 300-cycle flow cell kit, producing 2 × 150 bp paired-end reads. Genome assembly and annotation were performed using the Bacterial and Viral Bioinformatics Resource Center (BV-BVRC) genome assembly and annotation service (v.3.49.1) [36]. Genome assembly was conducted via BV-BRC using the SPAdes assembly strategy (SPAdes v4.0) [37]. Annotation was performed using the Genome Annotation tool in BV-BRC with the “Bacteriophages” annotation recipe.

2.4. Phage Host Range

To assess the host range of the isolated phages, spot tests were performed on the E. coli C laboratory strain and the previously described 66 E. coli strains of Garretto et al. [3] using the same methods as described previously. Following incubation, plates were examined for zones of lysis. Furthermore, dilutions were plated to assess phage efficacy. Clear zones were recorded as strong lytic activity (plaque formation), zones with no evidence of lytic activity (no plaque), or incomplete zones (“cloudy” plaques) as partial lysis or incomplete lysogeny. Supplemental Figure S1 shows an example of one of these dilutions in which the plaques are not clear but rather appear cloudy.

2.5. Transmission Electron Microscopy (TEM)

For TEM analysis, phages were prepared by applying filtered cell-free supernatant to thin carbon-coated copper grids and allowing them to adsorb onto thin carbon films for 2 min. Then, the films were negatively stained with 2% aqueous uranyl acetate for 1 min. Samples were observed using a JEOL 1400 Flash TEM (Boston, MA, USA).

2.6. Phage Genome Analysis

Phage genome sequences were first queried against the nr/nt database, restricting the search to viruses (taxonomy ID: 10239). Sequences also were examined using ICTV’s TaxaBLAST (version VMR_MSL40.v1.20250307.3437cb9) [38]; the closest species exemplar sequence was then retrieved from NCBI and compared to the phage genome sequence via VIRIDIC, using the web version of the tool with default parameters [39]. Peduovirus genomes were compared with clinker [40], using the web version of the tool. Default parameters were used with the following exceptions: “Show only best links” was selected and the identity threshold was set to 0.7. Integrase amino acid sequences were extracted from annotations and aligned using MAFFT v7.490 [41] using default parameters via Geneious Prime v2024.0.7. A phylogenetic tree was derived using FastTree v2.1.11 [42], again using default parameters via Geneious Prime, and visualized using iTOL v7 [43]. Lastly, genomes were examined for Anti-CRISPR (Acr) genes using AcrHub [44]. Phage genomes were individually uploaded to the server, and all three (PaCRISPR, AcRanker, and HMM-based predictor) were selected, specifying the “For normal use” option.

3. Results

Sixty-six urinary E. coli strains were grown and tested for spontaneous induction; these strains have been previously characterized by our lab [3] and each genome was examined for the presence of prophages (Supplemental Table S1 and Supplemental File S1). Filtered cell-free supernatants were plated on the laboratory strain E. coli C, as described in the Methods, and plaques were purified. In total, 20 temperate phages were successfully induced. While the bacterial strains tested included >1 predicted prophage (Table 1), through plaque purification, a single phage was isolated from each lysogen. (The predicted prophage sequences from the draft genomes for the strains in which a phage was isolated are provided in Supplemental File S1.) These temperate phages were from E. coli strains isolated from females with and without lower urinary tract symptoms and include phylogenetically distinct E. coli strains, representative of phylogroups A, B1, B2, D, and F.

3.1. Host Range Analysis

The host range of each phage was assessed using spot assays on the full panel of 66 urinary E. coli strains and the well characterized laboratory strain E. coli C. Plaque phenotypes were visually classified as either clear or cloudy to indicate complete versus partial lysis, respectively (Figure 1). (An example of a “cloudy” plaque can be seen in Supplemental Figure S1.)
Across all 20 phages tested, we observed considerable variability in host range, with no single phage capable of infecting all 66 urinary bacterial strains. The number of susceptible hosts per phage ranged from as few as 2 to as many as 32. Phage 103 showed the broadest host range, lysing 32 out of the 66 tested urinary strains (48.5%), indicating a capacity for cross-strain infectivity. Other phages with moderately broad host ranges include phage 906 (14/66, 21.2%), phage 109 (13/66, 19.7%), and phage 3461 (13/66, 19.7%). Of the 20 phages examined, 6 phages (30%) were capable of lysing 10 or more strains. Most phages, however, exhibited more narrow host ranges. Phages 1160 and 3461 each lysed 7 strains, while phages 1162 and 527 lysed 5 strains. Several phages showed extremely limited infectivity, including phages 1225, 5814, and 6890 each of which lysed only 2 strains, and phages 149 and 1180, which infected only 3 strains.
Superinfection immunity is common among E. coli lysogens [45,46,47,48,49,50,51] and could explain the limited lysis observed; 54 of the 66 strains tested contain prophages themselves. Only 12 of the urinary E. coli strains are not predicted to encode for a prophage (UMB1356, UMB1346, UMB1354, UMB1360, UMB1347, UMB1012, UMB1359, UMB1223, UMB2328, UMB2055, UMB5337, and UMB6471) (Figure 1, indicated with an asterisk). These 12 strains represent the only unbiased substrate for detecting lysis uninfluenced by prophage-mediated defense. For example, phage 103, which lysed 33 E. coli strains overall, was able to lyse 5 of the 12 prophage-free strains (UMB1346, UMB1223, UMB2055, UMB5337, and UMB6471). Phages 1160, 1162, and 931 showed more instances of lysis on prophage-free strains rather than lysogens, suggesting that they may be particularly susceptible to superinfection exclusions. Phages with very limited host range (phages 1225, 5814, and 6890) did not infect any of the prophage-free strains, indicating inherently narrow tropism, integration into these bacterial hosts, or complete inhibition by intracellular defenses. Notably, when we examine phage infectivity across these prophage-free strains, some phages that otherwise showed limited host range produced plaques more consistently.

3.2. TEM Imaging

Phage morphology was characterized using TEM, which revealed distinct, structural features characteristic of the Caudoviricetes class (previously known as Caudovirales) of tailed phages with double-stranded DNA genomes [52]. In Figure 2, TEM images of the 20 isolated induced phages are shown. Here we can see that most of the isolated phages—6890, 5814, 1335, 1162, 906, 1160, 933, 923, 149, 109, 931, 6712, 3461, 6454, and 1225—exhibited features characteristic of myoviruses, with notably rigid, contractile tails. This group includes both broad host range phages (906, 1162, and 1335) and narrow host range phages (933 and 1225), highlighting the variety of host ranges within this morphology.
A single siphovirus phage was detected, phage 1526, which exhibited a long, flexible, non-contractile tail. This family is often associated with temperate phages, and while some siphoviruses can infect diverse hosts, they typically display narrower host ranges [53,54]. However, phage 1526 exhibited a moderate host range, infecting 13 of 55 tested strains (19.7%). Three phages—103, 527, and 1362—were identified as likely podoviruses, possessing short, non-contractile tails. Interestingly, phage 103 displayed the broadest host range in this study, lysing 32 of 66 strains (48.5%), whereas 527 and 1362 exhibited much narrower ranges.

3.3. Genome Sequence Analysis

Next, the induced phages were sequenced, and their genomes assembled and annotated. Details about their genome sequences can be found in Supplemental Table S2. Each phage genome was then queried against all characterized virus sequences in GenBank via BLAST (Table 2). In cases in which the genome sequence identified via this BLAST search had an assigned tail morphology, we have included this in Table 2. While no morphological information was available for 12 of these GenBank records, we should note that two of the phages identified via TEM as podoviruses (phages 527 and 1362) exhibit the greatest sequence similarity to known podoviruses; phage 103, also identified as a podovirus, exhibits the greatest sequence similarity to an uncharacterized phage. While TEM imaging suggests that phage 906 is a myovirus (Figure 2), its sequence is most similar to a characterized podovirus (query coverage = 56%, percent identity = 96.05%).
As Table 2 shows, only nine of the phage genomes were most similar to characterized phages. Next, we compared the sequences to the International Committee on Taxonomy of Viruses (ICTV) species exemplar sequences. (Due to the fragmentation of the sequences for phages 1335 and 6713, we have excluded them from this analysis.) The intergenomic similarity reported in Table 2 and illustrated in Supplemental Figure S2 indicates that all of the phages isolated are representatives of new species, as none exceed the 95% threshold set forth by the ICTV [52]. However, we can confidently assign six of the induced phages to a genus, as the intergenomic similarity exceeds the 70% threshold [52]. Coincidentally, they are all members of the genus Peduovirus. None of the other phages meet this genus threshold, although phages 933 and 6890 are close. This suggests representatives of putative new genera.
Further investigation of the phages identified as members of the genus Peduovirus was conducted. As shown in Figure 3A, phages 1180, 6454, 1225, and 149 are representatives of the same species; their intergenomic similarity exceeds 99%. Likewise, phages 1091 and 1162 represent the same species (intergenomic similarity = 98.9%). The inclusion of five ICTV species exemplar sequences in Figure 3A confirms their membership in the genus. We can thus conclude that the induced prophages represent two new Peduovirus species. Significant amino acid similarity is observed between the coding regions of all six phages (Figure 3B).
The annotated phage sequences were further examined, identifying integrase coding regions in 13 of the 20 genome sequences. No integrase was identified for phages 923, 931, 3641, 5814, 6890, nor the two fragmented assemblies. All 13 integrases are predicted to be tyrosine recombinases. A phylogenetic tree of these integrase amino acid sequences was derived (Figure 4). Of note is the placement of phage 1526, which was similar to—although not meeting the genus threshold—Peduoviruses (Table 2). Phages 527 and 906 form a distinct clade, which parallels their distinction both visually as podoviruses and their similarity to sequences of the genus Lederbergvirus.
Given the presence of CRISPR spacers within the urinary E. coli strains tested for permissivity to the induced phages (Supplemental Table S1), the phage genomes were examined for Anti-CRISPR (Acr) proteins. As shown in Supplemental Table S3, all but phage 933 contained at least one predicted Arc. Note, no very close homologs to experimentally verified Acrs were identified. Further investigation into the predicted genes is needed to ascertain if these coding regions assist with overcoming the bacterial host defense system.

4. Discussion

Previous work by our group has isolated temperate phages from urinary isolates, e.g., [15,30,31,57]. With the recent evidence suggesting that temperate phages may contribute to uropathogen colonization [33], we focused our efforts on further understanding coliphages. E. coli colonizing the urinary tract can itself be diverse, representing most of the phylogroups for the species, both in healthy individuals and those with UTIs [3,58,59,60,61]. Given this diversity, we previously investigated urinary E. coli genomes, finding prophages predicted to represent all three phage tail morphologies [15]. Here, we were able to induce and reliably replicate temperate phages from diverse urinary E. coli strains (Table 1).
Our host range analysis of the 20 induced prophages shows significant variation. Most of the induced phages could not infect the host from which they were induced; only phages 1162 and 933 produced cloudy plaques and phage 103 was able to completely lyse its source strain (Figure 1). Notably, six phages (1225, 5814, 149, 6890, 1161, and 1012) were restricted to being able to successfully lyse just 2–4 hosts. However, the absence of observable plaques should not be interpreted as the inability to infect the bacterium. In many cases, temperate phages may adsorb and inject their DNA successfully into the bacterial cell but enter the lysogenic cycle instead of initiating lysis, resulting in no visible plaque formation [62]. Alternatively, even when the lytic cycle is attempted, bacterial defenses can mask the true breadth of some phages’ ability to infect a host cell [63]. These defenses, including restriction modification (RM) systems, CRISPR-Cas immunity, or prophage-mediated superinfection exclusion, can interfere with phage replication and abort the infection [64,65,66]. While prior studies have found the CRISPR-Cas and other “anti-phage” defenses abundant among E. coli [67], 30 of the 66 E. coli strains tested here did not encode for the CRISPR-Cas system (Supplemental Table S1). Phage defenses against the CRISPR-Cas system, also known as anti-CRISPR genes, have been identified for several species, although a full catalog of these genes across the prokaryotic tree of life has yet to be generated [68]. Anti-CRISPR genes were predicted in all but one of the induced phage genomes, although no genes homologous to experimentally verified genes were identified (Supplemental Table S3). Further investigation of these predicted Acr genes and other defense systems that may be encoded within these phage genomes is needed.
The six phages (1091, 1162, 149, 1180, 6454, and 1225), which most closely resembled the well-studied family of P2-like temperate myoviruses [69], varied in their host-ranges (Figure 1). Phage 1225 only fully lysed two of the E. coli strains tested and phages 149 and 1180 fully lysed three. Phage 1162 fully lysed six and phage 6454 fully lysed seven E. coli strains. This is in contrast to phage 1091, which fully lysed 14 of the E. coli strains tested. Even phages representative of the same species varied in the number of E. coli strains lysed, with phage 1091 exhibiting a much broader host range than 1162. The bacterial strains lysed also varied. The variation in host range observed fits with prior studies. Host range can vary between closely related phages in the same species [70,71,72]; in fact, a single “well-placed” mutation can result in dramatically different host ranges for two phages [73]. It should be noted that phage 1180, which was initially predicted to be a siphovirus (Figure 2), genome sequencing suggests that the induced phage is a Peduovirus. Because induction was repeated for this particular E. coli strain, it could be that we have imaged one temperate phage—a siphovirus—while sequencing another—a Peduovirus.
In a recent study of coliphages from fecal samples of 1 year old children, lytic phages had a broader host range than temperate phages when tested against E. coli isolates from these same samples; temperate phages were able to lyse at most 9% of the 75 E. coli isolates tested [74]. In contrast, we identified temperate coliphages with substantially greater host range, most notably phage 103, which successfully lysed nearly half of the 66 urinary E. coli strains. Phage 103 sequencing and comparison to characterized phages indicate that this phage has yet to be isolated, showing the greatest sequence homology to a MAG (Table 2). TEM imaging suggests that this phage is a podovirus (Figure 2). In a recent study of coliphages isolated from sewage and agricultural fecal samples, podoviruses were found to have the narrowest host-range [75]. Phages 527 and 1362 isolated here, however, exhibited much narrower ranges.
While myoviruses were the most common phage morphology observed, no consistent relationship between morphology and host lysis was observed. Most of the urinary strains tested for host range assays were lysogens themselves. The majority of bacteria in the urinary tract are lysogens [14], and recent research has found that lysogeny is prevalent in high-density bacterial populations, such as is the case with UTIs [33]. Furthermore, it is likely that superinfection immunity plays a significant role in determining coliphage-E. coli interactions. This too can have implications for phage therapy used to treat E. coli-associated UTIs [76], thus warranting continued investigation of temperate phages in the urinary tract.
Half of the temperate phages identified here did not exhibit sequence similarity to characterized phages, instead resulting in BLAST hits to MAGs (Table 2). This suggests that there remains a wealth of diverse coliphages in the human body that have yet to be characterized, although metagenomics has provided a glimpse into this diversity. Using ICTV tools, we identified the species exemplar sequence most similar to each of the phage genomes and assessed the intergenomic similarity. While we did not find instances in which the induced phage was a representative of one of these characterized species, we did find instances of phages induced from different E. coli strains, isolated from different individuals, that were representatives of the same species. In fact, we have characterized here two new Peduovirus species. Our comparison of the Peduovirus genomes finds protein sequence similarity despite non-collinearization of the phage genomes. This echoes a previous observation in which Peduovirus genomes isolated from clinical samples had mosaic architectures [77].
We would be remiss to not mention that the phages examined here are but a subset of predicted prophages in the 66 urinary E. coli strains (Supplemental Table S1 and Supplemental File S1). We selected for temperate phages capable of both infecting and lysing E. coli C and undergoing induction under the growth conditions used here. Testing cell-free supernatant on additional E. coli strains would likely identify additional temperate phages. For instance, Pacifico et al. used E. coli DSM 12242 to isolate phages from urine samples [77]. Induced coliphages from urinary E. coli isolates were purified using E. coli B, E. coli C, and E. coli K-12 by Crum et al. [15], and Almosuli et al. used E. coli B and UPEC E. coli CFT073 [33]. Furthermore, treatments such as UV light or mitomycin C would likely induce additional temperate phages. As we have previously shown, temperate coliphages can be induced from urinary E. coli strains through changes in a culture’s pH [57]. Even with the limited conditions employed here, a diverse collection of prophages infectious of urinary E. coli was catalogued, prompting subsequent studies into coliphages and their role in the urinary microbiota.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/v18020179/s1, Table S1. Details about 66 urinary E. coli isolates and their genomes; Table S2. Details about the 20 induced E. coli phage genomes; Table S3. Acrs predicted for the induced E. coli phage genomes; Figure S1. Example of dilutions of induced prophages on E. coli lawns in which the plaques are not clear, but rather they appear cloudy; Figure S2. VIRIDIC heatmap comparing the phage genomes to TaxaBLAST-identified ICTV species exemplar virus sequences. The upper triangle lists the intergenomic similarity (%) while the lower triangle lists the fraction (between 0 and 1) of the genome that aligned. Three measures are provided for the genome alignment: the aligned fraction genome 1 (row genome), genome length ratio (for the two genomes in the pair), and aligned fraction genome 2 (column genome); File S1. PHASTER predicted prophage sequences for E. coli genomes from which phages were isolated.

Author Contributions

H.A. conducted the investigation and was responsible for the acquisition, analysis, and interpretation of data, as well as drafting the initial manuscript. N.S. assisted in the investigation. C.P. was responsible for the conceptualization of the project and contributed to the review and editing of the final manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Institutes of Health (US) grant number R15 AI171873 to CP.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Genome accession numbers for the E. coli genomes are included in Supplemental Table S1. Genome accession numbers for the induced phages are included in Supplemental Table S2.

Acknowledgments

The authors would like to thank students in the 2023 Clinical Microbiology laboratory for their assistance in characterizing phages induced from the 66 clinical E. coli strains. Moreover, we thank members of the Wolfe lab at Loyola University Chicago (Maywood, IL, USA) for their work isolating these E. coli strains and providing them for our use.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Medina, M.; Castillo-Pino, E. An Introduction to the Epidemiology and Burden of Urinary Tract Infections. Ther. Adv. Urol. 2019, 11, 1756287219832172. [Google Scholar] [CrossRef]
  2. Thomas-White, K.J.; Gao, X.; Lin, H.; Fok, C.S.; Ghanayem, K.; Mueller, E.R.; Dong, Q.; Brubaker, L.; Wolfe, A.J. Urinary Microbes and Postoperative Urinary Tract Infection Risk in Urogynecologic Surgical Patients. Int. Urogynecology J. 2018, 29, 1797–1805. [Google Scholar] [CrossRef]
  3. Garretto, A.; Miller-Ensminger, T.; Ene, A.; Merchant, Z.; Shah, A.; Gerodias, A.; Biancofiori, A.; Canchola, S.; Canchola, S.; Castillo, E.; et al. Genomic Survey of E. coli from the Bladders of Women with and Without Lower Urinary Tract Symptoms. Front. Microbiol. 2020, 11, 2094. [Google Scholar] [CrossRef] [PubMed]
  4. Price, T.K.; Hilt, E.E.; Thomas-White, K.; Mueller, E.R.; Wolfe, A.J.; Brubaker, L. The Urobiome of Continent Adult Women: A Cross-Sectional Study. BJOG Int. J. Obstet. Gynaecol. 2020, 127, 193–201. [Google Scholar] [CrossRef]
  5. Touchon, M.; Bernheim, A.; Rocha, E.P.C. Genetic and Life-History Traits Associated with the Distribution of Prophages in Bacteria. ISME J. 2016, 10, 2744–2754. [Google Scholar] [CrossRef]
  6. Touchon, M.; Perrin, A.; De Sousa, J.A.M.; Vangchhia, B.; Burn, S.; O’Brien, C.L.; Denamur, E.; Gordon, D.; Rocha, E.P. Phylogenetic Background and Habitat Drive the Genetic Diversification of Escherichia coli. PLoS Genet. 2020, 16, e1008866. [Google Scholar] [CrossRef]
  7. Dobrindt, U.; Agerer, F.; Michaelis, K.; Janka, A.; Buchrieser, C.; Samuelson, M.; Svanborg, C.; Gottschalk, G.; Karch, H.; Hacker, J. Analysis of Genome Plasticity in Pathogenic and Commensal Escherichia coli Isolates by Use of DNA Arrays. J. Bacteriol. 2003, 185, 1831–1840. [Google Scholar] [CrossRef]
  8. Popa, O.; Landan, G.; Dagan, T. Phylogenomic Networks Reveal Limited Phylogenetic Range of Lateral Gene Transfer by Transduction. ISME J. 2017, 11, 543–554. [Google Scholar] [CrossRef] [PubMed]
  9. López-Leal, G.; Camelo-Valera, L.C.; Hurtado-Ramírez, J.M.; Verleyen, J.; Castillo-Ramírez, S.; Reyes-Muñoz, A. Mining of Thousands of Prokaryotic Genomes Reveals High Abundance of Prophages with a Strictly Narrow Host Range. mSystems 2022, 7, e00326-22. [Google Scholar] [CrossRef] [PubMed]
  10. Molari, M.; Shaw, L.P.; Neher, R.A. Quantifying the Evolutionary Dynamics of Structure and Content in Closely Related E. coli Genomes. Mol. Biol. Evol. 2025, 42, msae272. [Google Scholar] [CrossRef] [PubMed]
  11. Giannattasio-Ferraz, S.; Ene, A.; Gomes, V.J.; Queiroz, C.O.; Maskeri, L.; Oliveira, A.P.; Putonti, C.; Barbosa-Stancioli, E.F. Escherichia coli and Pseudomonas Aeruginosa Isolated from Urine of Healthy Bovine Have Potential as Emerging Human and Bovine Pathogens. Front. Microbiol. 2022, 13, 764760. [Google Scholar] [CrossRef]
  12. Fong, K.; Lu, Y.T.; Brenner, T.; Falardeau, J.; Wang, S. Prophage Diversity Across Salmonella and Verotoxin-Producing Escherichia coli in Agricultural Niches of British Columbia, Canada. Front. Microbiol. 2022, 13, 853703. [Google Scholar] [CrossRef]
  13. Hayashi, T.; Makino, K.; Ohnishi, M.; Kurokawa, K.; Ishii, K.; Yokoyama, K.; Han, C.G.; Ohtsubo, E.; Nakayama, K.; Murata, T.; et al. Complete Genome Sequence of Enterohemorrhagic Escherichia coli O157:H7 and Genomic Comparison with a Laboratory Strain K-12. DNA Res. Int. J. Rapid Publ. Rep. Genes Genomes 2001, 8, 11–22. [Google Scholar] [CrossRef]
  14. Miller-Ensminger, T.; Garretto, A.; Brenner, J.; Thomas-White, K.; Zambom, A.; Wolfe, A.J.; Putonti, C. Bacteriophages of the Urinary Microbiome. J. Bacteriol. 2018, 200, e00738-17. [Google Scholar] [CrossRef] [PubMed]
  15. Crum, E.; Merchant, Z.; Ene, A.; Miller-Ensminger, T.; Johnson, G.; Wolfe, A.J.; Putonti, C. Coliphages of the Human Urinary Microbiota. PLoS ONE 2023, 18, e0283930. [Google Scholar] [CrossRef]
  16. Ramisetty, B.C.M.; Sudhakari, P.A. Bacterial “Grounded” Prophages: Hotspots for Genetic Renovation and Innovation. Front. Genet. 2019, 10, 65. [Google Scholar] [CrossRef]
  17. Brenes, L.R.; Laub, M.T. E. coli Prophages Encode an Arsenal of Defense Systems to Protect against Temperate Phages. Cell Host Microbe 2025, 33, 1004–1018.e5. [Google Scholar] [CrossRef]
  18. Bondy-Denomy, J.; Davidson, A.R. When a Virus Is Not a Parasite: The Beneficial Effects of Prophages on Bacterial Fitness. J. Microbiol. 2014, 52, 235–242. [Google Scholar] [CrossRef]
  19. Harrison, E.; Brockhurst, M.A. Ecological and Evolutionary Benefits of Temperate Phage: What Does or Doesn’t Kill You Makes You Stronger. BioEssays News Rev. Mol. Cell. Dev. Biol. 2017, 39, 1700112. [Google Scholar] [CrossRef] [PubMed]
  20. Lederberg, E.M.; Lederberg, J. Genetic studies of lysogenicity in Escherichia coli. Genetics 1953, 38, 51–64. [Google Scholar] [CrossRef]
  21. Bobay, L.-M.; Rocha, E.P.C.; Touchon, M. The Adaptation of Temperate Bacteriophages to Their Host Genomes. Mol. Biol. Evol. 2013, 30, 737–751. [Google Scholar] [CrossRef]
  22. Li, X.; Gallardo, O.; August, E.; Dassa, B.; Court, D.L.; Stavans, J.; Arbel-Goren, R. Stability and Gene Strand Bias of Lambda Prophages and Chromosome Organization in Escherichia coli. mBio 2024, 15, e0207823. [Google Scholar] [CrossRef]
  23. Nanda, A.M.; Thormann, K.; Frunzke, J. Impact of Spontaneous Prophage Induction on the Fitness of Bacterial Populations and Host-Microbe Interactions. J. Bacteriol. 2015, 197, 410–419. [Google Scholar] [CrossRef]
  24. Breitbart, M.; Hewson, I.; Felts, B.; Mahaffy, J.M.; Nulton, J.; Salamon, P.; Rohwer, F. Metagenomic Analyses of an Uncultured Viral Community from Human Feces. J. Bacteriol. 2003, 185, 6220–6223. [Google Scholar] [CrossRef]
  25. Reyes, A.; Haynes, M.; Hanson, N.; Angly, F.E.; Heath, A.C.; Rohwer, F.; Gordon, J.I. Viruses in the Faecal Microbiota of Monozygotic Twins and Their Mothers. Nature 2010, 466, 334–338. [Google Scholar] [CrossRef] [PubMed]
  26. Minot, S.; Sinha, R.; Chen, J.; Li, H.; Keilbaugh, S.A.; Wu, G.D.; Lewis, J.D.; Bushman, F.D. The Human Gut Virome: Inter-Individual Variation and Dynamic Response to Diet. Genome Res. 2011, 21, 1616–1625. [Google Scholar] [CrossRef]
  27. Lopez, J.A.; McKeithen-Mead, S.; Shi, H.; Nguyen, T.H.; Huang, K.C.; Good, B.H. Abundance Measurements Reveal the Balance between Lysis and Lysogeny in the Human Gut Microbiome. Curr. Biol. 2025, 35, 2282–2294.e11. [Google Scholar] [CrossRef]
  28. Avellaneda-Franco, L.; Dahlman, S.; Barr, J.J. The Gut Virome and the Relevance of Temperate Phages in Human Health. Front. Cell. Infect. Microbiol. 2023, 13, 1241058. [Google Scholar] [CrossRef] [PubMed]
  29. Henrot, C.; Petit, M.-A. Signals Triggering Prophage Induction in the Gut Microbiota. Mol. Microbiol. 2022, 118, 494–502. [Google Scholar] [CrossRef]
  30. Garretto, A.; Miller-Ensminger, T.; Wolfe, A.J.; Putonti, C. Bacteriophages of the Lower Urinary Tract. Nat. Rev. Urol. 2019, 16, 422–432. [Google Scholar] [CrossRef]
  31. Johnson, G.; Wolfe, A.J.; Putonti, C. Characterization of the ϕCTX-like Pseudomonas Aeruginosa Phage Dobby Isolated from the Kidney Stone Microbiota. Access Microbiol. 2019, 1, e000002. [Google Scholar] [CrossRef] [PubMed]
  32. Brassil, B.; Mores, C.R.; Wolfe, A.J.; Putonti, C. Characterization and Spontaneous Induction of Urinary Tract Streptococcus Anginosus Prophages. J. Gen. Virol. 2020, 101, 685–691. [Google Scholar] [CrossRef]
  33. Almosuli, M.; Kirtava, A.; Chkhotua, A.; Tsveniashvili, L.; Chanishvili, N.; Irfan, S.S.; Ng, E.; McIntyre, H.; Hockenberry, A.J.; Araujo, R.P.; et al. Urinary Bacteriophage Cooperation with Bacterial Pathogens during Human Urinary Tract Infections Supports Lysogenic Phage Therapy. Commun. Biol. 2025, 8, 175. [Google Scholar] [CrossRef] [PubMed]
  34. Arndt, D.; Grant, J.R.; Marcu, A.; Sajed, T.; Pon, A.; Liang, Y.; Wishart, D.S. PHASTER: A Better, Faster Version of the PHAST Phage Search Tool. Nucleic Acids Res. 2016, 44, W16–W21. [Google Scholar] [CrossRef]
  35. Couvin, D.; Bernheim, A.; Toffano-Nioche, C.; Touchon, M.; Michalik, J.; Néron, B.; Rocha, E.P.C.; Vergnaud, G.; Gautheret, D.; Pourcel, C. CRISPRCasFinder, an Update of CRISRFinder, Includes a Portable Version, Enhanced Performance and Integrates Search for Cas Proteins. Nucleic Acids Res. 2018, 46, W246–W251. [Google Scholar] [CrossRef]
  36. Olson, R.D.; Assaf, R.; Brettin, T.; Conrad, N.; Cucinell, C.; Davis, J.J.; Dempsey, D.M.; Dickerman, A.; Dietrich, E.M.; Kenyon, R.W.; et al. Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): A Resource Combining PATRIC, IRD and ViPR. Nucleic Acids Res. 2023, 51, D678–D689. [Google Scholar] [CrossRef] [PubMed]
  37. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing. J. Comput. Biol. J. Comput. Mol. Cell Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef]
  38. Black, E.J.; Powell, C.S.; Dempsey, D.M.; Hendrickson, R.C.; Mims, L.R.; Lefkowitz, E.J. Virus Taxonomy: The Database of the International Committee on Taxonomy of Viruses. Nucleic Acids Res. 2025, 54, D776–D789. [Google Scholar] [CrossRef]
  39. Moraru, C.; Varsani, A.; Kropinski, A.M. VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses. Viruses 2020, 12, 1268. [Google Scholar] [CrossRef]
  40. Gilchrist, C.L.M.; Chooi, Y.-H. Clinker & Clustermap.Js: Automatic Generation of Gene Cluster Comparison Figures. Bioinformatics 2021, 37, 2473–2475. [Google Scholar] [CrossRef]
  41. Katoh, K.; Standley, D.M. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability. Mol. Biol. Evol. 2013, 30, 772–780. [Google Scholar] [CrossRef]
  42. Price, M.N.; Dehal, P.S.; Arkin, A.P. FastTree 2—Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE 2010, 5, e9490. [Google Scholar] [CrossRef]
  43. Letunic, I.; Bork, P. Interactive Tree of Life (iTOL) v6: Recent Updates to the Phylogenetic Tree Display and Annotation Tool. Nucleic Acids Res. 2024, 52, W78–W82. [Google Scholar] [CrossRef] [PubMed]
  44. Wang, J.; Dai, W.; Li, J.; Li, Q.; Xie, R.; Zhang, Y.; Stubenrauch, C.; Lithgow, T. AcrHub: An Integrative Hub for Investigating, Predicting and Mapping Anti-CRISPR Proteins. Nucleic Acids Res. 2021, 49, D630–D638. [Google Scholar] [CrossRef] [PubMed]
  45. Lindahl, G.; Sironi, G.; Bialy, H.; Calendar, R. Bacteriophage Lambda; Abortive Infection of Bacteria Lysogenic for Phage P2. Proc. Natl. Acad. Sci. USA 1970, 66, 587–594. [Google Scholar] [CrossRef]
  46. Toothman, P.; Herskowitz, I. Rex-Dependent Exclusion of Lambdoid Phages II. Determinants of Sensitivity to Exclusion. Virology 1980, 102, 147–160. [Google Scholar] [CrossRef] [PubMed]
  47. Lu, M.J.; Henning, U. The Immunity (Imm) Gene of Escherichia coli Bacteriophage T4. J. Virol. 1989, 63, 3472–3478. [Google Scholar] [CrossRef]
  48. Oberto, J.; Weisberg, R.A.; Gottesman, M.E. Structure and Function of the Nun Gene and the Immunity Region of the Lambdoid Phage HK022. J. Mol. Biol. 1989, 207, 675–693. [Google Scholar] [CrossRef]
  49. Uc-Mass, A.; Loeza, E.J.; De La Garza, M.; Guarneros, G.; Hernández-Sánchez, J.; Kameyama, L. An Orthologue of the Cor Gene Is Involved in the Exclusion of Temperate Lambdoid Phages. Evidence That Cor Inactivates FhuA Receptor Functions. Virology 2004, 329, 425–433. [Google Scholar] [CrossRef]
  50. Owen, S.V.; Wenner, N.; Dulberger, C.L.; Rodwell, E.V.; Bowers-Barnard, A.; Quinones-Olvera, N.; Rigden, D.J.; Rubin, E.J.; Garner, E.C.; Baym, M.; et al. Prophages Encode Phage-Defense Systems with Cognate Self-Immunity. Cell Host Microbe 2021, 29, 1620–1633.e8. [Google Scholar] [CrossRef]
  51. Rousset, F.; Depardieu, F.; Miele, S.; Dowding, J.; Laval, A.-L.; Lieberman, E.; Garry, D.; Rocha, E.P.C.; Bernheim, A.; Bikard, D. Phages and Their Satellites Encode Hotspots of Antiviral Systems. Cell Host Microbe 2022, 30, 740–753.e5. [Google Scholar] [CrossRef]
  52. Turner, D.; Kropinski, A.M.; Adriaenssens, E.M. A Roadmap for Genome-Based Phage Taxonomy. Viruses 2021, 13, 506. [Google Scholar] [CrossRef]
  53. Göller, P.C.; Haro-Moreno, J.M.; Rodriguez-Valera, F.; Loessner, M.J.; Gómez-Sanz, E. Uncovering a Hidden Diversity: Optimized Protocols for the Extraction of dsDNA Bacteriophages from Soil. Microbiome 2020, 8, 17. [Google Scholar] [CrossRef]
  54. Holtappels, D.; Fortuna, K.J.; Vallino, M.; Lavigne, R.; Wagemans, J. Isolation, Characterization and Genome Analysis of an Orphan Phage FoX4 of the New Foxquatrovirus Genus. BMC Microbiol. 2022, 22, 304. [Google Scholar] [CrossRef]
  55. Lopez-Diaz, M.; Bleriot, I.; Pacios, O.; Fernandez-Garcia, L.; Blasco, L.; Ambroa, A.; Ortiz-Cartagena, C.; Woodford, N.; Ellington, M.J.; Tomas, M. Molecular Characteristics of Phages Located in Carbapenemase-Producing Escherichia coli Clinical Isolates: New Phage-Like Plasmids. bioRxiv 2022. [Google Scholar] [CrossRef]
  56. Li, P.; Yong, S.; Zhou, X.; Shen, J. Characterization of a New Temperate Escherichia coli Phage vB_EcoP_ZX5 and Its Regulatory Protein. Pathogens 2022, 11, 1445. [Google Scholar] [CrossRef] [PubMed]
  57. Miller-Ensminger, T.; Garretto, A.; Stark, N.; Putonti, C. Mimicking Prophage Induction in the Body: Induction in the Lab with pH Gradients. PeerJ 2020, 8, e9718. [Google Scholar] [CrossRef]
  58. Staji, H.; Rassouli, M.; Jourablou, S. Comparative Virulotyping and Phylogenomics of Escherichia coli Isolates from Urine Samples of Men and Women Suffering Urinary Tract Infections. Iran. J. Basic Med. Sci. 2019, 22, 211–214. [Google Scholar] [CrossRef] [PubMed]
  59. Halaji, M.; Fayyazi, A.; Rajabnia, M.; Zare, D.; Pournajaf, A.; Ranjbar, R. Phylogenetic Group Distribution of Uropathogenic Escherichia coli and Related Antimicrobial Resistance Pattern: A Meta-Analysis and Systematic Review. Front. Cell. Infect. Microbiol. 2022, 12, 790184. [Google Scholar] [CrossRef]
  60. Kara, A.; Massaro, C.; Giammanco, G.M.; Alduina, R.; Boussoualim, N. Phylogenetic Diversity, Antibiotic Resistance, and Virulence of Escherichia coli Strains from Urinary Tract Infections in Algeria. Antibiotics 2024, 13, 773. [Google Scholar] [CrossRef]
  61. Mahshouri, P.; Alikhani, M.Y.; Momtaz, H.E.; Doosti-Irani, A.; Shokoohizadeh, L. Analysis of Phylogroups, Biofilm Formation, Virulence Factors, Antibiotic Resistance and Molecular Typing of Uropathogenic Escherichia coli Strains Isolated from Patients with Recurrent and Non-Recurrent Urinary Tract Infections. BMC Infect. Dis. 2025, 25, 267. [Google Scholar] [CrossRef]
  62. Mäntynen, S.; Laanto, E.; Oksanen, H.M.; Poranen, M.M.; Díaz-Muñoz, S.L. Black Box of Phage-Bacterium Interactions: Exploring Alternative Phage Infection Strategies. Open Biol. 2021, 11, 210188. [Google Scholar] [CrossRef]
  63. Canchaya, C.; Proux, C.; Fournous, G.; Bruttin, A.; Brüssow, H. Prophage Genomics. Microbiol. Mol. Biol. Rev. MMBR 2003, 67, 238–276. [Google Scholar] [CrossRef] [PubMed]
  64. Lu, M.-J.; Henning, U. Superinfection Exclusion by T-Even-Type Coliphages. Trends Microbiol. 1994, 2, 137–139. [Google Scholar] [CrossRef]
  65. Barrangou, R.; Fremaux, C.; Deveau, H.; Richards, M.; Boyaval, P.; Moineau, S.; Romero, D.A.; Horvath, P. CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes. Science 2007, 315, 1709–1712. [Google Scholar] [CrossRef]
  66. Pleška, M.; Guet, C.C. Effects of Mutations in Phage Restriction Sites during Escape from Restriction–Modification. Biol. Lett. 2017, 13, 20170646. [Google Scholar] [CrossRef] [PubMed]
  67. Hochhauser, D.; Millman, A.; Sorek, R. The Defense Island Repertoire of the Escherichia coli Pan-Genome. PLoS Genet. 2023, 19, e1010694. [Google Scholar] [CrossRef] [PubMed]
  68. Pons, B.J.; Van Houte, S.; Westra, E.R.; Chevallereau, A. Ecology and Evolution of Phages Encoding Anti-CRISPR Proteins. J. Mol. Biol. 2023, 435, 167974. [Google Scholar] [CrossRef]
  69. Christie, G.E.; Calendar, R. Bacteriophage P2. Bacteriophage 2016, 6, e1145782. [Google Scholar] [CrossRef]
  70. Lynch, K.H.; Dennis, J.J. Cangene Gold Medal Award Lecture—Genomic Analysis and Modification of Burkholderia Cepacia Complex Bacteriophages. Can. J. Microbiol. 2012, 58, 221–235. [Google Scholar] [CrossRef]
  71. Shaer Tamar, E.; Kishony, R. Multistep Diversification in Spatiotemporal Bacterial-Phage Coevolution. Nat. Commun. 2022, 13, 7971. [Google Scholar] [CrossRef]
  72. Sergueev, K.V.; Filippov, A.A.; Farlow, J.; Su, W.; Kvachadze, L.; Balarjishvili, N.; Kutateladze, M.; Nikolich, M.P. Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus. Appl. Environ. Microbiol. 2019, 85, e01209-19. [Google Scholar] [CrossRef] [PubMed]
  73. Le, S.; He, X.; Tan, Y.; Huang, G.; Zhang, L.; Lux, R.; Shi, W.; Hu, F. Mapping the Tail Fiber as the Receptor Binding Protein Responsible for Differential Host Specificity of Pseudomonas Aeruginosa Bacteriophages PaP1 and JG004. PLoS ONE 2013, 8, e68562. [Google Scholar] [CrossRef] [PubMed]
  74. Mathieu, A.; Dion, M.; Deng, L.; Tremblay, D.; Moncaut, E.; Shah, S.A.; Stokholm, J.; Krogfelt, K.A.; Schjørring, S.; Bisgaard, H.; et al. Virulent Coliphages in 1-Year-Old Children Fecal Samples Are Fewer, but More Infectious than Temperate Coliphages. Nat. Commun. 2020, 11, 378. [Google Scholar] [CrossRef] [PubMed]
  75. Korf, I.H.E.; Meier-Kolthoff, J.P.; Adriaenssens, E.M.; Kropinski, A.M.; Nimtz, M.; Rohde, M.; van Raaij, M.J.; Wittmann, J. Still Something to Discover: Novel Insights into Escherichia coli Phage Diversity and Taxonomy. Viruses 2019, 11, 454. [Google Scholar] [CrossRef]
  76. Morgan, C.J.; Atkins, H.; Wolfe, A.J.; Brubaker, L.; Aslam, S.; Putonti, C.; Doud, M.B.; Burnett, L.A. Phage Therapy for Urinary Tract Infections: Progress and Challenges Ahead. Int. Urogynecology J. 2025, 36, 1343–1353. [Google Scholar] [CrossRef]
  77. Pacífico, C.; Hilbert, M.; Sofka, D.; Dinhopl, N.; Pap, I.-J.; Aspöck, C.; Carriço, J.A.; Hilbert, F. Natural Occurrence of Escherichia coli-Infecting Bacteriophages in Clinical Samples. Front. Microbiol. 2019, 10, 2484. [Google Scholar] [CrossRef]
Viruses 18 00179 g001
Figure 1. Phage host range across clinical urinary E. coli isolates and lab strain E. coli C. The heatmap shows the outcome of spot assays for each phage-bacterium pair. Red squares indicate clear plaques, representing productive lytic infection. Dark blue indicates cloudy plaques, suggestive of incomplete lysogeny. Light blue indicates no visible plaque, suggesting no infection or complete resistance. Bacterial strains with no prophages are denoted by an asterisk (*) and listed in the top rows. Black boxes throughout the heatmap represent a phage infecting the host from which it was isolated. (Beyond ordering by *, there is no specific ordering of either bacteria or phage in the figure).
Figure 1. Phage host range across clinical urinary E. coli isolates and lab strain E. coli C. The heatmap shows the outcome of spot assays for each phage-bacterium pair. Red squares indicate clear plaques, representing productive lytic infection. Dark blue indicates cloudy plaques, suggestive of incomplete lysogeny. Light blue indicates no visible plaque, suggesting no infection or complete resistance. Bacterial strains with no prophages are denoted by an asterisk (*) and listed in the top rows. Black boxes throughout the heatmap represent a phage infecting the host from which it was isolated. (Beyond ordering by *, there is no specific ordering of either bacteria or phage in the figure).
Viruses 18 00179 g001
Viruses 18 00179 g002
Figure 2. TEM of phages isolated from urinary E. coli lysogens. Representative TEM images of 20 phages showing the structural diversity across the Caudoviricetes class. Each color corresponds to a different morphology: green for myoviruses; blue for podoviruses; red for siphoviruses. Each panel (A–T) depicts a distinct phage isolate: (A) 6890, (B) 5814, (C) 1526, (D) 1180, (E) 1335, (F) 1162, (G) 906, (H) 1160, (I) 933, (J) 923, (K) 149, (L) 1091, (M) 103, (N) 931, (O) 527, (P) 6713, (Q) 3461, (R) 6454, (S) 1225, and (T) 1362.
Figure 2. TEM of phages isolated from urinary E. coli lysogens. Representative TEM images of 20 phages showing the structural diversity across the Caudoviricetes class. Each color corresponds to a different morphology: green for myoviruses; blue for podoviruses; red for siphoviruses. Each panel (A–T) depicts a distinct phage isolate: (A) 6890, (B) 5814, (C) 1526, (D) 1180, (E) 1335, (F) 1162, (G) 906, (H) 1160, (I) 933, (J) 923, (K) 149, (L) 1091, (M) 103, (N) 931, (O) 527, (P) 6713, (Q) 3461, (R) 6454, (S) 1225, and (T) 1362.
Viruses 18 00179 g002
Viruses 18 00179 g003
Figure 3. Comparison of phage isolate genome sequences similar to peduoviruses. (A) The upper triangle lists the intergenomic similarity (%) while the lower triangle lists the fraction (between 0 and 1) of the genome that aligned. Three measures are provided for the genome alignment: the aligned fraction genome 1 (row genome), genome length ratio (for the two genomes in the pair), and aligned fraction genome 2 (column genome). (B) Annotated coding regions are indicated by arrows, pointing in the direction of their orientation. Homologous genes are displayed in the same color and connected between the four phage sequences via lines. These lines are shaded from light to dark based on the amino acid sequence identity. Arrows shaded gray do not have homologs in any of the other genomes.
Figure 3. Comparison of phage isolate genome sequences similar to peduoviruses. (A) The upper triangle lists the intergenomic similarity (%) while the lower triangle lists the fraction (between 0 and 1) of the genome that aligned. Three measures are provided for the genome alignment: the aligned fraction genome 1 (row genome), genome length ratio (for the two genomes in the pair), and aligned fraction genome 2 (column genome). (B) Annotated coding regions are indicated by arrows, pointing in the direction of their orientation. Homologous genes are displayed in the same color and connected between the four phage sequences via lines. These lines are shaded from light to dark based on the amino acid sequence identity. Arrows shaded gray do not have homologs in any of the other genomes.
Viruses 18 00179 g003
Viruses 18 00179 g004
Figure 4. Tree of identified integrase amino acid sequences. Branch supports are shown.
Figure 4. Tree of identified integrase amino acid sequences. Branch supports are shown.
Viruses 18 00179 g004
Table 1. Bacterial host information for the 20 induced phages. Symptoms: No LUTS = no lower urinary tract symptoms, OAB = overactive bladder symptoms, UTI = Urinary tract infection, UUI = urge urinary incontinence.
Table 1. Bacterial host information for the 20 induced phages. Symptoms: No LUTS = no lower urinary tract symptoms, OAB = overactive bladder symptoms, UTI = Urinary tract infection, UUI = urge urinary incontinence.
Phage IDBacterial StrainBacterial PhylotypeParticipant SymptomNo. Predicted Prophages
103UMB0103FOAB3
1091UMB1091B23UTI5
149UMB0149AOAB5
527UMB527AOAB6
906UMB906B23UTI5
923UMB923B1UTI4
931UMB931DUTI6
933UMB0933B22No LUTS3
1160UMB1160B23UTI6
1162UMB1162B23UTI6
1180UMB1180B1UTI2
1225UMB1225DUTI2
1335UMB1335DUTI6
1362UMB1362B1UTI3
1526UMB1526B23UTI2
3641UMB3641DUUI4
5814UMB5814B23UUI2
6454UMB6454B2UTI5
6713UMB6713B23No LUTS4
6890UMB6890B23UUI4
Table 2. Sequence similarity to GenBank viral sequences and ICTV species exemplar virus sequences. This table summarizes each phage isolated, including the bacterial strain from which it was isolated and the phage record that has the closest sequence similarity to via BLAST. The genus and tail morphology of this nearest neighbor phage hit were determined either via the taxonomy listed in the BLAST record or from the literature (as noted in the table). a Per ICTV, this phage genome sequence is only available via the complete genome sequence of the S. enterica subsp. enterica serovar Typhimurium str. LT2 chromosome sequence, but it is located at position 2,844,298–2,877,981. b Values in bold exceed the genus threshold of 70%. c If no tail morphology is listed for the GenBank record, it is not included in the table. Tail morphology codes are as follows: M = myovirus, P = podovirus.
Table 2. Sequence similarity to GenBank viral sequences and ICTV species exemplar virus sequences. This table summarizes each phage isolated, including the bacterial strain from which it was isolated and the phage record that has the closest sequence similarity to via BLAST. The genus and tail morphology of this nearest neighbor phage hit were determined either via the taxonomy listed in the BLAST record or from the literature (as noted in the table). a Per ICTV, this phage genome sequence is only available via the complete genome sequence of the S. enterica subsp. enterica serovar Typhimurium str. LT2 chromosome sequence, but it is located at position 2,844,298–2,877,981. b Values in bold exceed the genus threshold of 70%. c If no tail morphology is listed for the GenBank record, it is not included in the table. Tail morphology codes are as follows: M = myovirus, P = podovirus.
Phage IDNCBI BLAST ResultsICTV TaxaBLAST ResultsPredicted Tail Morphology c
Nearest Neighbor Strain (Genus; Accession No.)Query CoveragePercent IdentitySpecies Exemplar Virus (Genus; Accession No.)Intergenomic Similarity b
103MAG: Caudoviricetes sp. isolate MSP1011 (Uncharacterized; OR222389)64% 80.37%Escherichia phage 2H10 (Glaedevirus; LR595862.1)30.0
1091Peduovirus P22H4 (Peduovirus; LR595869.1)80% 97.66%Enterobacteria phage fiAA91-ss (Peduovirus; KF322032.1)72.6M
149Escherichia Phage 12W (Peduovirus; OM475434)77%96.80%Escherichia phage P2_4E6b (Peduovirus; LR595885.1)80.1M
527Escherichia phage phiv205-1 (Lederbergvirus; MN340231)51%96.32%Enterobacteria phage HK620 (Lederbergvirus; AF335538.1)35.8P
906Enterobacteria phage CUS-3 (Lederbergvirus; CP000711)56%96.05%Enterobacteria phage HK620 (Lederbergvirus; AF335538.1)35.9P
923Escherichia phage vB_EcoM-683R1 (Uncharacterized; ON470593)72%97.10%Salmonella phage SEN34 (Brunovirus; KT630649.1)31.3M [55]
931MAG: Bacteriophage sp. isolate 2344_22993 (Uncharacterized; OP074524)92%99.97%Escherichia phage P2 (Peduovirus; KC618326.1)4.7
933MAG: Caudoviricetes sp. isolate ctZgU1 (Uncharacterized; BK021527)98%95.66%Salmonella phage PsP3 (Eganvirus; AY135486.1)63.8
1160MAG: Bacteriophage sp. isolate 1228_163631 (Uncharacterized; OP073762)100%100%Escherichia phage P2 (Peduovirus; KC618326.1)0.3
1162Escherichia virus P2_2H4 (Peduovirus; LR595869)82%97.4%Escherichia phage P2_2H1 (Peduovirus; LR595870.1)77.6M
1180MAG: Bacteriophage sp. Isolate 0195_16858 (Uncharacterized; OP073076)84%97.8%Escherichia phage P2_4E6b (Peduovirus; LR595885.1)80.8
1225MAG: Bacteriophage sp. isolate 0195_16858 (Uncharacterized; OP073076)83%97.80%Escherichia phage P2_4E6b (Peduovirus; LR595885.1)80.2
1335MAG: Bacteriophage sp. isolate 1105_17178 (Uncharacterized; OP073677)100%99.81%--
1362Escherichia phage vB_EcoP_ZX5 (Uetakevirus; MW722083)100%100%Escherichia phage phiV10 (Uetakevirus; DQ126339.2)59.5P [56]
1526Escherichia phage vB_EcoM-12474III (Peduovirus; MK907237)74% 97.59%Yersinia phage GMG73 (Peduovirus; OP880301.3)45.2M
3641MAG: Bacteriophage sp. isolate 2344_22993 (Uncharacterized; OP074524)81%99.97%Salmonella phage Fels2 (Felsduovirus; AE006468.2 a)1.2
5814MAG: Caudoviricetes sp. isolate ctc4i17 (Uncharacterized; BK019137)70%98.26%Salmonella phage Fels2 (Felsduovirus; AE006468.2 a)0.1
6454MAG: Bacteriophage sp. isolate 0195_16858 (Uncharacterized; OP073076)83%97.81%Escherichia phage P2_4E6b (Peduovirus; LR595885.1)80.1
6713MAG: Bacteriophage sp. isolate 1105_17178 (Uncharacterized; OP073677)79%100%--
6890Escherichia phage D108 (Muvirus; GQ357916)96%96.52%Escherichia phage Mu (Muvirus; AF083977.1)68.3M
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Atkins, H.; Stegman, N.; Putonti, C. Diverse Temperate Coliphages of the Urinary Tract. Viruses 2026, 18, 179. https://doi.org/10.3390/v18020179

AMA Style

Atkins H, Stegman N, Putonti C. Diverse Temperate Coliphages of the Urinary Tract. Viruses. 2026; 18(2):179. https://doi.org/10.3390/v18020179

Chicago/Turabian Style

Atkins, Haley, Natalie Stegman, and Catherine Putonti. 2026. "Diverse Temperate Coliphages of the Urinary Tract" Viruses 18, no. 2: 179. https://doi.org/10.3390/v18020179

APA Style

Atkins, H., Stegman, N., & Putonti, C. (2026). Diverse Temperate Coliphages of the Urinary Tract. Viruses, 18(2), 179. https://doi.org/10.3390/v18020179

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop